Nosho et al. [136] examined the prognostic role of tumor-infiltrating T-cell subsets (CD3+, CD8+, CD45RO+, and FOXP3+) in a large series of 768 CRCs from two prospective cohort studies. The gene discussed is CD8A; the disease is neoplasm.